Get started

PFE

Ex-dividend date - An end to investors' hesitation?Good evening. Price has remained awfully quiet in anticipation of bad headlines. When those headlines actually arrived (23 elderly patients dead in Norway), they were swept under the rug by media world-wide, or just shrugged off. Source: Bloomberg - Pfizer Vaccine Safe for Elderly Despite Norway Scare, WHO Says Price has remained extremely stable around 36.22-37.78$ but the ex-dividend date is 28th of January, which means if investors were looking to buy but were hesitant, they'll have to pull the trigger in the coming 2 days or miss out on the dividends of the quarter. Q4 2020 Earnings report is expected on the 2nd of February. Might be exactly what PFE needs to break out towards 42.50$ again. Especially considering the company's pledge to make 1.3 to 2 billion doses in 2021. P.S.: Pfizer is looking at a 50% COVID vaccine earnings split with BioNTech, or even slightly more. Source: Motley Fool - What Does 2021 Hold for BioNTech Stock?
NYSE:PFELong
by Conda400
1
Pfizer Analysis. 3 reasons to watch.Hello Everyone, I hope you all had a good start to the New Year. Pfizer (PFE) has been in the news a lot recently due to their vaccine. There may also be a few reasons to keep an eye on their stock price. 1) Support/Resistance- PFE ended the year with a pull-back. The price is currently being supported around $37. Price has hit resistance at $37 three times since May 2020. Price broke through the resistance in Nov 2020 and appears to be forming a new support in this range. 2) Fibonacci Retracement- This support/resistance area ($37) also coincides with a 61.8% retracement from the most recent low from Oct 2020 (see attached chart). Price has not closed below the 61.8% retracement as of writing. 3) MACD Divergence- Looking at the MACD/price chart, the MACD is diverging from the price. Hidden Bullish Divergence formed on the price chart/MACD at $37. This may further prove price has found a new support at $37. I would personally like to see a close above the 50-day EMA prior to entering any trades so I will continue to watch closely. Thank you for reading and please do your own research before trading
NYSE:PFELong
by pofseur
1
PFE 37: Boring but good Risk/Reward in a dangerous market PFE is an enormously profitable company that is not in fashion with the momo crowd or the new kids chasing sexy names. It is however an A+ company with staying power and good dividend yield, a better alternative to bonds in today's near-zero interest rate. As SPY correction is highly likely, it is perhaps a place to park some cash. Also, the market has shown some interest in routing into real economy stocks (with real revenue and profit). TGT, WMT, GE for instance. Technically it has turned upwards, after a sharp and quick sell-off from 43, after all the covid vaccine news. 1st Target is 40.50 To be long around 37 or sell PCS of 37/33. If needed lunch money, one could also sell ATM weekly calls that give out a 2% weekly premium. This is a plan, obviously not any sort of advice.
NYSE:PFELong
by Jonas99
7 day scare windowThe vaccine stocks didn't explode this week as some of us holding the stocks were hoping for. Either the news was priced in for some stocks, or (as I believe is the case for TMO), it needs another catalyst to really jump back into its bullish channel (green channel -- which has a possible target of 530 - 560!) I have updated the cycles for TMO and think it sits a bit better in the updated cycle analysis. TMO is in a tight wedge at the moment, but today or tomorrow should give some indication which side it will break towards. 7 Days Risky Window I hate to say it, but I am seeing this window with a number of stocks since over a month. Seeing now that indexes are over-extended and are just hanging on the stimulus news, I see a potential for a dip over the coming 7 days. The red arrows track this risk. This is only for the near term, as I see TMO bouncing off the 100MA and moving back up as vaccine news and earnings reports near towards January. Good luck!
NYSE:TMOLong
by Karam08
NYSE:PFE Pfizer stock price forecast, Buy Breakout, Target 68.45Pfizer (NYSE: PFE) Trade : Buy Breakout Entry : 42.84 Target : 68.45 (25.61, +59.78%) Stop : 37 (-5.84, -13.63%) Posted on Sunday, December 13, 2020 Note : Pharmaceutical stocks are drawing attention in connection with the COVID-19 (Coronavirus disease 2019) vaccine. Pfizer is one of them. There is no COVID-19 vaccine yet that everyone recognize the efficacy, and it is not known how long it will take. In other words, the prices of pharmaceutical stocks related to the COVID-19 vaccine could not be assured. Pfizer stock prices fell after hitting the resistance line of 42.84. If they strongly break out that price line again, it would be a sign of rise. In that case, the next resistance(target) could be 56.12 and 68.45. If the pharmaceutical market is very strong, we may see 99 or so. It would be better to find opportunities to buy when its stock price breaks out 42.84.
NYSE:PFELong
by Ptrade
6